Loading...
NPI 1932274743 · Conway, SC · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Coastal Carolina Centers Of Urology And Surgery LLC is a ambulatory surgical clinic/center provider located in Conway, South Carolina. This profile covers 30 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Coastal Carolina Centers Of Urology And Surgery LLC |
| Address | 822 Farrar Drive |
| City | Conway |
| State | SC |
| ZIP | 29526 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | November 21, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.5M |
| Medicaid | $0 |
The provider’s code mix is concentrated in neuromodulation and endoscopic urologic procedures, consistent with an Ambulatory Surgical Clinic/Center. High-revenue Medicare CPTs include implant and replacement of spinal and peripheral neurostimulator generators (63685, 63650, 64590) alongside cystourethroscopy and related transprostatic implant codes (C9740, 52356, 52332), indicating a hybrid practice that performs both implanted-device neuromodulation and procedural urology in an outpatient surgical setting.
Revenue is highly concentrated in a small set of Medicare procedures: the precomputed top three codes account for 54.7% of this provider’s total Medicare revenue, led by 63685 ($593.3K, 24.1%), 63650 ($460.7K, 18.7%), and 64590 ($291.9K, 11.9%). This concentration means changes in reimbursement or utilization for neuromodulation services would materially affect overall Medicare revenues.
Payer mix is effectively single-payer: lifetime Medicare revenue is $2.5M while there is no Medicaid billing on file. The absence of Medicaid activity reduces exposure to that payer’s rate environment but also indicates the provider relies almost entirely on Medicare revenue for public-payer volume.
Competitive standing on neuromodulation procedures is above-average but not dominant nationally: 63650 ranks #104 of 1371 providers (92th percentile) and, despite being labeled "typical, unremarkable volume," represents a relatively strong national position for that procedure; 63685 ranks #180 of 1281 (85th percentile) and 64590 ranks #162 of 561 (68th percentile), both described as typical volumes. In sum, the practice shows notable national activity for certain device-implant procedures without being the top-tier national leader.
For urologic endoscopic services the provider shows pockets of outsized activity relative to peers. Examples include 52356 at $65.8K (2.7% of Medicare revenue) ranking #170 of 3090 providers (94th percentile, labeled typical) and 52332 at $40.3K (1.6% of Medicare revenue) ranking #199 of 3938 providers (95th percentile, explicitly described as "notably above typical national volume"). Additionally, 55700 ($55.4K, 2.3%) ranks #146 of 4425 providers (97th percentile) and is also described as "notably above typical national volume," indicating localized specialty strength in certain cystoscopy/stent procedures.
One coding and operational note: 55700 is listed as deleted December 31, 2025, yet it currently represents $55.4K (2.3% of Medicare revenue) and a rank described as "notably above typical national volume." Expect near-term disruption or migration of that volume to replacement codes or billing patterns, which could affect year-over-year comparisons.
The NPI was enumerated on 2006-11-21 (~20 years ago), signaling long tenure in the market. Combined with concentrated high-revenue procedures, this longevity suggests an established specialty practice with stable procedural lines rather than a recently diversified operation.
Strategic and reimbursement risk is concentrated around neuromodulation and implantable devices: the top revenue-driving codes are device- and procedure-focused, so shifts in coverage policies, device utilization, or coding rules would have outsized revenue impact. The provider’s lack of Medicaid billing reduces exposure to Medicaid-specific rate changes but also limits diversification of public-payer revenue streams.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
30 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 63685 | The provider inserts or replaces a spinal neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that requires a connection… | 30 | $17,980 | $593.3K |
| 63650 | In this procedure, the provider places electrodes in the epidural space to relieve pain and reduce or eliminate spasms. | 130 | $3,570 | $460.7K |
| 64590 | The provider inserts or replaces a peripheral, sacral, or gastric neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that… | 20 | $13,900 | $291.9K |
| 0275T | N/A | 60 | $3,500 | $206.4K |
| C9740 | Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants | 40 | $5,250 | $199.3K |
| 64561 | The provider, under imaging guidance, implants electrodes around nerves in the sacral region to reduce the pain along the path of the nerve. | 30 | $3,630 | $123.3K |
| 64555 | A neurostimulator includes electrodes which are inserted under the skin and induced by a generator to stimulate the nerve tissue. Use of this stimulator involves implantation of electrodes around a… | 30 | $4,070 | $114K |
| 64581 | The provider uses an open approach to implant a sacral nerve neurostimulator electrode array. Placement is transforaminal, meaning through the foramen (the opening sacral nerves run through). This… | 20 | $3,880 | $77.5K |
| 52356 | The provider performs a cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 40 | $1,570 | $65.8K |
| 55700 | Code deleted December 31, 2025. | 90 | $610 | $55.4K |
Showing 1–10 of 30
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 30 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
30 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| C9740 | 2 | 10 | 30 | $5,190 | $181.8K |
| 63685 | 9 | 40 | 20 | $5,770 | $138.5K |
| 64590 | 5 | 10 | 20 | $5,830 | $110.8K |
| 64555 | 4 | 10 | 30 | $1,860 | $74.5K |
| 63650 | 1 | 40 | 40 | $1,580 | $66.5K |
| 64561 | 4 | 20 | 20 | $2,150 | $64.5K |
| 0275T | 1 | 10 | 20 | $1,680 | $45.5K |
| 64483 | 57 | 130 | 90 | $190 | $33K |
| 64581 | 2 | 10 | 20 | $1,800 | $30.7K |
| 64493 | 113 | 130 | 70 | $170 | $22.7K |
Showing 1–10 of 30
Other providers in the same ZIP code as Coastal Carolina Centers Of Urology And Surgery LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.